One Year of JOURNAVX in Practice: Emerging Real-World Insights from the First Approved NaV1.8 Pain Therapy
9:00 am - Wednesday 27th January 2027
- Review recently published real-world and Phase IV evidence evaluating JOURNAVX use in clinical practice
- Examine emerging data on opioid-sparing outcomes and the evolving role of non-opioid therapies in acute pain management
- Explore prescribing patterns and treatment utilization trends from the growing body of post-launch evidence
- Discuss key considerations for advancing future pain therapies, including remaining challenges around efficacy, access, reimbursement, and demonstrating value beyond opioids